You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 8,673,636


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,673,636
Title:Method for enzymatic treatment, device and kit used the same
Abstract: One embodiment provides a method for enzymatic treatment, including the steps of forming a closed space on a local tissue area with a device and infusing an enzyme solution into the closed space for enzymatic treatment. The method according to the embodiment is capable of treating the local tissue area with enzymes for enhancing cell proliferation in the treated tissue area and preventing damage of the adjacent normal tissues. A device and kit used for the method are also provided.
Inventor(s): Jiang; Ching-Chuan (Taipei, TW), Liao; Chun-Jen (Taipei, TW), Chang; Wen-Hsiang (Hsinchu, TW), Chen; Huang-Chi (Chiayi, TW), Liao; Wei-Ju (Taichung, TW), Wang; Wen-Hsi (Taipei, TW)
Assignee: Industrial Technology Research Institute (Hsinchu, TW)
Application Number:13/614,766
Patent Claims:1. A method for enzymatic treatment, comprising: forming a closed space on a local tissue area, and infusing an enzyme solution into the closed space, wherein the closed space is formed by a device immobilized on a tissue surface, the device comprises a hollow cavity including a first side and a second side at the opposite side, the first side comprises at least two openings, wherein at least one of the at least two openings is an in-put opening, and wherein at least one of the at least two openings is an out-put opening, wherein the at least one in-put opening is connected with an infusion element and wherein the at least one out-put opening is connected with an extraction element, the second side comprises at least one opening, wherein at least one of the at least one openings is immobilized on a tissue surface to form the closed space between the hollow cavity and the tissue surface, and wherein the enzyme solution is infused into the closed space with the infusion element and extracted from the closed space with the extraction element.

2. The method as claimed in claim 1, wherein the infusion element comprises a container part and an infusion opening connected to the input opening for infusing the enzyme solution into the closed space.

3. The method as claimed in claim 1, wherein the extraction element comprises an extraction part and an extraction opening connected to the out-put opening for extracting fluids out from the closed space.

4. The method as claimed in claim 1, wherein the hollow cavity further comprises extrusions on both flanks of the second side for immobilization of the hollow cavity on the tissue surface.

5. The method as claimed in claim 4, wherein the extrusion is 3-5 mm from the flank of the second side.

6. The method as claimed in claim 4, wherein the extrusion is 3-5 mm from the end of the second side.

7. The method as claimed in claim 1, wherein the device is immobilized on the tissue surface by using pre-fixation equipment.

8. The method as claimed in claim 1, wherein the hollow cavity consists of a biocompatible material.

9. The method as claimed in claim 8, wherein the biocompatible material comprises polyether ether ketone (PEEK), stainless steel or silicone.

10. The method as claimed in claim 1, wherein the tissue comprises cartilage tissues, bone tissues or nerve tissues.

11. The method as claimed in claim 1, wherein the enzyme solution comprises collagenase, hyaluronidase, trypsin, lipase, proteinase or a combination thereof.

12. The method as claimed in claim 1, wherein the concentration of the enzyme solution is 2-5 U/ml.

13. The method as claimed in claim 1, wherein the infusion of the enzyme solution takes 5 minutes to 1 hour.

Details for Patent 8,673,636

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 05/05/2004 ⤷  Try a Trial 2032-05-04
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 12/02/2004 ⤷  Try a Trial 2032-05-04
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 10/26/2004 ⤷  Try a Trial 2032-05-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.